Marimed (MRMD) Capital Leases (2019 - 2026)

Marimed (MRMD) has 8 years of Capital Leases data on file, last reported at $1.6 million in Q1 2026.

• Capital Leases for Q1 2026 came in at $1.6 million, down 18.05% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.6 million (down 18.05% YoY), and the FY2025 annual result was $2.0 million, up 1.56% from the prior year.
• Capital Leases slipped to $1.6 million in Q1 2026 per MRMD's latest filing, from $2.0 million in the prior quarter.
• Over five years, Capital Leases peaked at $2.7 million in Q2 2024 and troughed at $338000.0 in Q2 2022.
• A 5-year average of $1.6 million and a median of $1.9 million in 2025 frame the typical range for Capital Leases.
• The sharpest annual moves came in 2022 and 2026: Capital Leases surged 1995.45% in 2022, then fell 18.05% in 2026.
• A 5-year view of Capital Leases shows it stood at $461000.0 in 2022, then soared by 364.21% to $2.1 million in 2023, then dropped by 10.0% to $1.9 million in 2024, then rose by 1.56% to $2.0 million in 2025, then slipped by 19.94% to $1.6 million in 2026.
• Business Quant data shows MRMD's Capital Leases at $1.6 million in Q1 2026, $2.0 million in Q4 2025, and $2.2 million in Q3 2025.